Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Role of Molecular Aging of Matrix Proteins of the Vessel Wall in the Aneurysm Pathology

Authors not listed

CHU de Reims · 2015

Abstract

During their biological life, proteins undergo molecular aging due to many non-enzymatic post-translational modifications that alter their structural and functional properties. These reactions concern all proteins but especially tissue proteins (whose half-life in the organism can be several decades) and lead to the formation of complex products called PTMDPs ("post-translational modification derived products"). Molecular aging is responsible for the alteration of protein properties which may cause changes in mechanical properties of tissues during aging and pathologies. However, the involvement of these processes in vivo remains unclear, particularly in the aneurysmal pathology. So, the aim of this study is to determine whether the molecular aging of matrix proteins within the vessel wall may participate in the development of aortic aneurysm.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-06 MST

Cite this

APA
Anonymous. (2015). Role of Molecular Aging of Matrix Proteins of the Vessel Wall in the Aneurysm Pathology. <em>CHU de Reims</em>. https://clinicaltrials.gov/study/NCT02784769
Vancouver
Anonymous. Role of Molecular Aging of Matrix Proteins of the Vessel Wall in the Aneurysm Pathology. CHU de Reims. 2015.
BibTeX
@misc{anon2015Roleof, title = {Role of Molecular Aging of Matrix Proteins of the Vessel Wall in the Aneurysm Pathology}, author = {Anonymous}, journal = {CHU de Reims}, year = {2015}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings